| Literature DB >> 32456164 |
Jorge Giménez-Meseguer1, Juan Tortosa-Martínez1, Juan M Cortell-Tormo1.
Abstract
Physical exercise seems to have a promising effect on numerous variables related to the recovery of drug-dependent patients. However, some contradictions are found in the literature. The aim of this study was to perform a systematic review and meta-analysis in order to identify the effect of physical exercise on mental disorders, quality of life, abstinence, and craving, and make a comparison of the effect of exercise depending on the type of program. A search for articles was conducted using PubMed, Web of Science, and Scopus databases. Studies were selected that measured the acute effects or long-term effect (≥2 weeks) of exercise in patients who met criteria for alcohol use disorders or substance use disorders. A total of 59 studies were included. An effect of exercise on mental disorders (standardized mean differences (SMD) = 0.66 (confidence interval (CI): 0.46, 0.86); z = 6.50; p < 0.00001) and quality of life (SMD = 0.69 (95% CI: 0.53, 0.84); z = 8.65; p < 0.00001) was identified. Subgroup analysis revealed an effect of exercise in craving (SMD = 0.80 (CI: 0.07, 1.53); z = 2.15, p = 0.03), stress (SMD = 1.11 (CI: 0.31, 1.91); = 2.73; p = 0.006), anxiety (SMD = 0.50 (CI: 0.16, 0.84); z = 2.88; p = 0.004) and depression (SMD = 0.63 (CI: 0.34, 0.92); z = 4.31; p < 0.0001). Body-mind activities and programs based on improving physical conditions produced similar results in mental disorders and quality of life. Available evidence indicates that physical exercise, both body-mind and physical fitness programs, can be effective in improving mental disorders, craving, and quality of life in drug-dependent patients.Entities:
Keywords: anxiety; craving; depression; drug addiction; mental disorders; physical activity; physical exercise; quality of life; stress; substance use disorders
Year: 2020 PMID: 32456164 PMCID: PMC7277811 DOI: 10.3390/ijerph17103680
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flowchart of the study selection process.
Methodological quality of the included studies. (PEDro Scale).
| Article | 1. Election Criteria | 2. RTC | 3. Blind Assignm. | 4. Baseline Similar. | 7. Blind Eval. | 8. Measur. of >85% | 9. Intent to Treat | 10. Between Groups | 11. Variab. Measures | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| Gary et al. [ | No | Yes | No | Yes | No | Yes | No | No | Yes | 4/9 |
| Frankel et al. [ | No | No | No | No | No | No | No | No | Yes | 1/9 |
| Piorkowski et al. [ | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | 8/9 |
| McKelvy et al. [ | Yes | Yes | Yes | Yes | No | Yes | No | No | Yes | 6/9 |
| Sinyor et al. [ | No | No | No | No | No | No | No | No | Yes | 1/9 |
| Palmer et al. [ | Yes | No | No | Yes | No | No | No | Yes | No | 3/9 |
| Burling et al. [ | Yes | No | No | Yes | No | No | No | Yes | No | 3/9 |
| Palmer et al. [ | Yes | Yes | Yes | Yes | No | No | No | No | Yes | 5/9 |
| Donaghy et al. [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | 6/9 |
| Ermalinski et al. [ | No | No | No | No | No | No | No | Yes | No | 1/9 |
| Shaffer et al. [ | Yes | Yes | Yes | Yes | No | No | No | Yes | No | 5/9 |
| Li et al. [ | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | 8/9 |
| Ussher et al. [ | Yes | Yes | No | Yes | No | Yes | Yes | Yes | Yes | 7/9 |
| Vedamurthachar et al. [ | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | No | 7/9 |
| Sareen et al. [ | Yes | Yes | Yes | Yes | No | Yes | Yes | No | No | 6/9 |
| Khalsa et al. [ | Yes | No | No | No | No | No | No | No | Yes | 2/9 |
| Weinstock et al. [ | Yes | No | No | No | No | Yes | No | Yes | Yes | 4/9 |
| Brown et al. [ | Yes | No | No | No | No | No | No | No | Yes | 2/9 |
| Brown et al. [ | Yes | No | No | No | No | No | No | No | Yes | 2/9 |
| Chen et al. [ | No | No | No | Yes | No | No | No | Yes | No | 2/9 |
| Mamen et al. [ | No | No | No | No | No | No | No | Yes | Yes | 2/9 |
| Roessler et al. [ | Yes | No | No | No | No | No | No | No | No | 1/9 |
| Buchowski et al. [ | Yes | No | No | No | No | Yes | No | No | Yes | 3/9 |
| Mamen et al. [ | No | No | No | No | No | No | No | Yes | Yes | 2/9 |
| Dolezal et al. [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | 6/9 |
| Li et al. [ | Yes | Yes | Yes | No | No | No | No | Yes | Yes | 5/9 |
| Roessler et al. [ | Yes | No | No | No | No | No | No | No | Yes | 2/9 |
| Smelson et al. [ | Yes | Yes | Yes | No | No | Yes | No | Yes | Yes | 6/9 |
| Zhuang et al. [ | Yes | Yes | Yes | Yes | No | Yes | No | Yes | Yes | 7/9 |
| Brown et al. [ | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | 8/9 |
| Cutter et al. [ | Yes | Yes | Yes | No | No | Yes | No | Yes | Yes | 6/9 |
| Devi et al. [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | 6/9 |
| Dolezal et al. [ | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | 8/9 |
| Flemmen et al. [ | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | 7/9 |
| Hallgren et al. [ | Yes | Yes | Yes | No | No | No | No | Yes | Yes | 5/9 |
| Jamurtas et al. [ | No | No | No | No | No | Yes | Yes | Yes | Yes | 4/9 |
| Muller et al. [ | Yes | No | No | No | No | No | No | Yes | No | 2/9 |
| Agarwal et al. [ | Yes | Yes | Yes | Yes | No | No | No | No | Yes | 5/9 |
| Dhawan et al. [ | Yes | Yes | No | Yes | No | No | No | Yes | Yes | 5/9 |
| Georgakouli et al. [ | Yes | No | No | Yes | No | Yes | Yes | Yes | Yes | 6/9 |
| Giménez et al. [ | Yes | No | No | Yes | No | No | No | Yes | Yes | 4/9 |
| Rawson et al. [ | Yes | Yes | Yes | Yes | No | Yes | No | Yes | Yes | 7/9 |
| Wang et al. [ | Yes | No | No | No | No | Yes | Yes | No | Yes | 4/9 |
| Brown et al. [ | Yes | Yes | Yes | No | No | No | No | No | Yes | 4/9 |
| Ciccolo et al. [ | Yes | No | No | No | No | No | No | No | Yes | 2/9 |
| Grandjean da Costa et al. [ | Yes | No | No | No | No | No | No | No | Yes | 2/9 |
| De la Garza et al. [ | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | 8/9 |
| Giesen et al. [ | Yes | No | No | Yes | No | No | No | Yes | Yes | 4/9 |
| Wang et al. [ | Yes | Yes | No | Yes | No | Yes | Yes | Yes | Yes | 7/9 |
| Zhu et al. [ | Yes | No | No | No | No | Yes | No | Yes | Yes | 4/9 |
| Colledge et al. [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | 6/9 |
| Georgakouli et al. [ | Yes | No | No | No | No | No | No | No | Yes | 2/9 |
| Roessler et al. [ | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | 8/9 |
| Trivedi et al. [ | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | 8/9 |
| Wang et al. [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | 6/9 |
| Carmody et al. [ | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | 7/9 |
| Jensen et al. [ | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | 6/9 |
| Roessler et al. [ | Yes | Yes | Yes | Yes | No | Yes | No | Yes | No | 6/9 |
| Zhang et al. [ | Yes | Yes | No | Yes | No | Yes | No | Yes | Yes | 6/9 |
Figure 2Trim and Fill funnel plot (Role Emotional).
Figure 3Trim and Fill funnel plot (Mental Health).
Description of studies that measure the acute effect of exercise on alcohol or other drugs.
| Article | Subst. | N (Exp + Control) | Program | Adherence (% Attendance) | Measuring Instruments | Main Results |
|---|---|---|---|---|---|---|
| Ussher et al. [ | Alcohol | 20 | 10 min of static bicycle. | - | Alcohol Urge Questionnaire | Decrease in the impulse to consume alcohol during exercise in an experimental group compared to the control group. |
| Jamurtas et al. [ | Alcohol | 17 | A mild intensity cycle ergometer session (55–60% FCM) | - | Alcohol Urge Questionnaire | Increase in B-endorphin levels |
| Georgakouli et al. [ | Alcohol | 34 (17 + 17) | A 30 min session of moderate intensity aerobic exercise (cycle ergometer) | - | Metabolic measurements | The response of liver enzymes was improved. |
| Wang et al. [ | Methamphetamine | 24 | Experimental session: 30 min of static bicycle moderate intensity (65–75% FC max) | - | Visual Analog Scale for craving measurement | Improvements in craving during, immediately after and 50 min after exercise, with respect to the control group. |
| Brown et al. [ | Alcohol | 26 | 12 weeks aerobic exercise moderate intensity | 70% | Likert scale (not validated) to measure mood and anxiety and craving. | Acute improvements after each exercise session in mood and anxiety. |
| Ciccolo et al. [ | Alcohol | 14 | A session (20 min) of strength and a passive display (20 min) of video. | 70% | Alcohol Use Disorders Identification Test (AUDIT) | Improvements in affection and arousal acutely. |
Studies that measure the effect of long-term exercise on alcohol use disorder (AUD) patients.
| Article | Substance | N (Exp + Control) | Program | Adherence (% Attendanc.) | Measuring Instruments | Main Results |
|---|---|---|---|---|---|---|
| Gary et al. [ | Alcohol | 20 | Experimental: 4 weeks, 5 sessions (run 1 mile per day) per week | - | Gough Adjective Check List | Significant improvements at the cardiovascular level |
| Frankel et al. [ | Alcohol | 214 | Experimental: 12 weeks of aerobic exercise y strength, 5 sessions (60 min) per week. | - | Cardiovascular and anthropometric measures | Significant improvements in physical conditions |
| Piorkowski et al. [ | Alcohol | 26 | Experimental: 4 weeks of circuit training, 5 sessions (55 min) per week | - | Stair climb | Improvements in physical conditions. |
| McKelvy et al. [ | Alcohol | 48 | Experimental: 4 weeks, 5 sessions (1,2 miles of running) per week at 85% FC max | - | One-Minute Step Test | Significant improvements in FC of rest and FC during effort. |
| Sinyor et al. [ | Alcohol | 79 | Experimental: 6 weeks of aerobic exercise and stretching, 5 sessions (40–50 min) per week | - | Cardio-physiological and anthropometric measurements | Greater abstinence from experimental group at the end of treatment and at 3 and 18 months of follow-up |
| Palmer et al. [ | Alcohol | 53 | Experimental: 4 weeks of aerobic exercise, 3 sessions (40–50 min) per week. | - | Zung Self-Rating Depression Scale | Improvements in anxiety and depression |
| Donaghy et al. [ | Alcohol | 158 | Experimental: Aerobic and strength exercises. | - | Test of physical conditions (Sit and reach, sit up, VO2) | There were no differences in abstinence |
| Ermalinski et al. [ | Alcohol | 90 | Experimental: 6 weeks of “body–mind-component” (yoga, jogging, motivational training) 5 sessions (90 min) per week. | - | Multidimensional Health Locus of Control Scales | Improvements in systolic blood pressure and aerobic capacity significantly |
| Vedamurthachar et al. [ | Alcohol | 60 | Experimental: 2 weeks of Sudarshana Kriya Yoga, 60 min of daily yoga | - | Beck Depression Inventory | Improvements in depression in both groups, but significantly more in the experimental group |
| Sareen et al. [ | Alcohol | 52 | 12 weeks of yoga, 3 sessions (60 min) per week | - | Short Form Health Survey (SF-36) | Significant improvements in quality of life, stress, mood, alcohol dependence and appetite. |
| Brown et al. [ | Alcohol | 19 | 12 weeks of aerobic exercise moderate intensity (1 day per week supervised, the rest autonomous) and 1 day weekly of teaching proper physical-sports habits. | 68% (to supervised sessions) | Structured Clinical Interview for DSM-IV | Abstinence improvements |
| Roessler et al. [ | Alcohol | 7 | 6 weeks of aerobic work, moderate intensity, 2 sessions per week | 59% | Bruce treadmill protocol | There were no significant improvements in physical conditions. |
| Brown et al. [ | Alcohol | 49 | 12 weeks of moderate intensity aerobic exercise (1 day per week supervised, the rest autonomous) and 1 day weekly of teaching proper physical-sports habits. | 70% (to supervised sessions) | Timeline Follow Back | Significant improvements in abstinence/alcohol consumption |
| Hallgren et al. [ | Alcohol | 14 | Experimental: 10 weeks of yoga, 1 session (90 min) weekly group. Patients were encouraged to perform yoga exercises autonomously. | - | Timeline Follow-back Method | Quantitative: |
| Brown et al. [ | Alcohol | 26 | 12 weeks of moderate intensity aerobic exercise | 70% | Likert scale (not validated) to measure mood and anxiety and craving. | Acute improvements in mood and anxiety. |
| Giesen et al. [ | Alcohol | 33 | Experimental: | - | Daily monitoring of physical activity levels | Significant improvements in quality of life (variables physical function, vitality, emotional role and mental health). |
| Georgakouli et al. [ | Alcohol | 20 (9 + 11) | 8 weeks of supervised exercise | - | Anthropometric and physiological measurements | Improvements in alcohol consumption and physical conditions. |
| Roessler et al. [ | Alcohol | 172 | 6 months of aerobic exercise, mild-moderate intensity, 2 sessions (30-60 min) per week | - | The Addiction Severity Index | There was no effect of the exercise program on alcohol consumption |
| Jensen et al. [ | Alcohol | 105 | 24 weeks of aerobic exercise, 2 sessions (30-60 min) per week | - | The Bruce treadmill protocol | Only the group that worked individually improved their VO2, but without significant differences between groups. |
| Roessler et al. [ | Alcohol | 116 (81 + 35) | 6 months of aerobic exercise, mild-moderate intensity, 2 sessions (30–60 min) per week. | - | The Inventory of Interpersonal Problems | There were no significant changes between the control and experimental groups in any of the 4 measured subscales. |
Studies that measure the effect of long-term exercise on substance use disorder (SUD) patients.
| Article | Population/Substance | N (Exp + Control) | Program | Adherence (%Attendance) | Measuring Instruments | Main Results |
|---|---|---|---|---|---|---|
| Burling et al. [ | SUD (varied substances) | 95 | Exp group: 4 weeks of softball, 1 session per week | - | Abstinence | Improvement in abstinence. |
| Palmer et al. [ | SUD (varied substances) | 45 | 4 weeks of supervised exercise, 3 sessions (30–40 min): | - | Health Status Questionnaire | Physical condition did not improve in any group |
| Shaffer et al. [ | SUD in maintenance with methadone | 59 | Exp. group: 22 weeks of yoga, 75min per session | - | Symptom check list | There were not significant differences in any variable between the two groups. |
| Li et al. [ | Heroin | 86 | Exp. group: 10 days of qigong, 25–30 min per session, without pharmacological treatment | 100% | Urine analysis | Significant improvement with respect to the control groups in symptoms of withdrawal syndrome, anxiety, and consumption. |
| Khalsa et al. [ | SUD (varied substances) | 8 | 90 days of yoga | - | The Perceived Stress Scale (PSS) | Improvement in the BASIS-32 and QRI test. |
| Weinstock et al. [ | SUD (varied substances) | 187 | G. exp: Chose at least one sport activity offered. | - | Addiction Severity Index | Improvements in abstinence in participants who did physical-sports activities. |
| Brown et al. [ | SUD (varied substances) | 16 | 12 weeks of moderate intensity aerobic exercise (1 day weekly supervised, the rest autonomous work) and 1 day weekly of teaching proper physical-sporting habits. | 71% (supervised sessions) | Structured Clinical Interview for DSM-IV | Abstinence improvements |
| Chen et al. [ | SUD (varied substances) | 207 | G. exp: qigong | Experimental group: 92% | Adjectuve Rating Scale for Withdrawal | Both groups improved in craving, sleep, anxiety, depression and symptoms of withdrawal syndrome, without significant differences between groups, except in craving, where qigong Group improved more than SMART group. |
| Mamen et al. [ | SUD (varied substances) | 33 | 7.5 months (300 h) of aerobic exercise (light intensity) individualized, with “trainer partners” | - | Lactate measurements | Significant improvements in aerobic power and production/elimination of lactate. |
| Roessler et al. [ | SUD (varied substances) | 20 | 2–6 months of aerobic exercise, 3 sessions (120 min) per week. | 52% | Indirect VO2 maximum test ( | Quantitative: |
| Buchowski et al. [ | Cannabis | 12 | 10 sessions (30 min) of moderate intensity supervised aerobic exercise. | 100% | Marijuana Craving Questionnaire | Less cannabis use during the program |
| Mamen et al. [ | SUD (varied substances) | 33 | Between 2–15 months (average duration: 7.5 months, 301 h) of aerobic exercise (mild intensity) individualized | - | Lactate measurements | Significant improvements in aerobic power and production/elimination of lactate. |
| Dolezal et al. [ | Methamphetamine | 29 | 8 weeks, 3 days (60 min) per week. | Experimental group: 92% | Scale, stadiometer and bending meter for anthropometric measurements | Significant improvements in VO2 and strength of legs and chest. |
| Li et al. [ | Heroine (women) | 33 | Experimental group: 6 months of tai chi, 2–3 sessions (60 min) per week. | - | Blood test | At the end of the program, there were no statistically significant differences between the two groups in any of the variables measured. |
| Smelson et al. [ | Cocaine | 86 | 2 weeks of qigong, between 4–6 sessions. | Experimental group: 90% | Cocaine Craving Questionnaire Brief | Improvements in craving and depression. |
| Zhuang et al. [ | Heroine (women) | 75 | Experimental group: 6 months of yoga, 5 sessions (50 min) per week. | 100% | The Profile of Mood States (POMS) | Improvements in quality of life (variables with physical role, pain, general health, vitality, emotional role and mental health). |
| Cutter et al. [ | Cocaine and/or opiates in maintenance with methadone | 27 (14 + 13?) | 8 weeks, 5 sessions (20–25 min) per week. | Experimental group: 63% | International Physical Activity Questionnaire-Long Version (IPAQ) | The experimental group showed higher levels of physical activity in their day to day (IPAQ) |
| Devi et al. [ | SUD (various substances) | 66 | Experimental group: 4 weeks of yoga, 70 min daily | - | Beck Depression Inventory | Significant improvements in depression and quality of life (domains physical health, psychological health and social relationships). |
| Dolezal et al. [ | Methamphetamine | 28 | 8 weeks, 3 days (60 min) per week. | Experimental group: 92% | Scale, stadiometer and bending meter for anthropometric measurements | Significant improvements in VO2 and strength of legs and chest |
| Flemmen et al. [ | SUD (various substances) | 16 | Experimental group: | 92% | Stress test (Cortex Metamax II portable metabolic test system) to assess VO2 and effort economy. | Significant improvement in VO2 |
| Muller et al. [ | SUD (various substances) | 35 | Experimental group: 10 weeks of aerobic exercise and light strength, 3 sessions (30 min) per week. | 69% | The World Health Organization Quality of Life Brief | Significant improvements in the domains “Physical Health” and “Psychological Health” of Quality of Life. |
| Agarwal et al. [ | Consumers of crack with HIV | 24 | Experimental: 8 weeks of yoga/Meditation, 2 sessions (60 min) per week. | 88% | Short Form 36 Health Survey (SF-36) | Significant improvements in perceived stress (PES and IES) |
| Dhawan et al. [ | Opiates | 84 | G. exp: 3 sessions (60 min) of yoga. | - | World Health Organization quality of life brief scale | Improvements in quality of life in the domains of physical health, psychological health and the environment. |
| Giménez et al. [ | SUD (various substances) | 37 | Experimental group: 12 weeks, 3 sessions (60–90 min) per week of aerobic endurance, strength-endurance and aerobic games, moderate intensity, | 81% | Six-Minute Walk Test (6MWT) | Quantitative: |
| Rawson et al. [ | Methamphetamine | 135 | Experimental group: 8 weeks of aerobic exercise (60–80% HRmax) and strength, 3 sessions (60 min) per week. | Experimental group: 72% | The Beck Depression Inventory | Significant improvements in anxiety and depression |
| Grandjean da Costa et al. [ | Crack and cocaine | 9 | 12 weeks aerobic exercise (running), 3 sessions (60 min) per week | 62% | Cooper 12-min test | Significant improvements at the cardiovascular and cognitive levels. |
| De la Garza et al. [ | Cocaine | 24 | 4 weeks, 3 sessions (30 min)/week: | - | Heart rate | Significant differences between the “runners” and “sedentary” groups in FC rest. |
| Zhu et al. [ | Methamphetamine | 59 | G. exp: 12 weeks of Tai chi, 5 sessions per week | - | Quality of life for drug addiction (QOL-DA) | Improvements in quality of life in the Tai chi group compared to the control group. |
| Colledge et al. [ | Heroine | 24 (11 + 13) | Experimental group: 12 weeks of varied exercise, two sessions per week | - | German version of the Centre for Epidemiologic Studies Depression Scale | The exercise group increased its daily exercise levels significantly, but no significant improvement was observed in any of the other variables measured. |
| Trivedi et al. [ | Stimulants | 302 (152+150) | Experimental group: 12 weeks of aerobic exercise, three sessions per week. | Experimental group: 64% | Timeline Follow Back | No significant differences between groups, but when controlling adherence, a significant improvement in abstinence was detected |
| Wang et al. [ | Methamphetamine | 50 (25 + 25) | G. exp: 12 weeks, 3 sessions (30 min) per week of moderate intensity aerobic exercise and behavioral treatment. | - | Visual analogue scale for craving measurement | Significant improvements in craving and self-control compared to control group. |
| Carmody et al. [ | Stimulant drugs | 218 (75 + 143) | Experimental group: 9 months of aerobic exercise, moderate-vigorous intensity, three sessions per week | - | Timeline Follow Back | The experimental group presented significantly lower probability of relapse and lower consumption in case of having a relapse than the control group. |
| Zhang et al. [ | Methamphetamine | 66 | G. exp: 12 weeks, 3 sessions (30 min) per week of ex. aerobic moderate intensity | - | CogState battery assessment | The experimental group improved the speed of information processing and fat oxidation. |
Figure 4Effect of the exercise on quality of life (all programs included).
Figure 5Effects of the exercise on mental disorders and craving (all programs included).
Figure 6Effect of physical fitness programs on quality of life.
Figure 7Effect of programs based on oriental practices on quality of life.
Figure 8Effect of physical fitness programs on mental disorders and craving.
Figure 9Effect of oriental practices on mental disorders and craving.